Ignite Creation Date:
2025-12-24 @ 1:02 PM
Ignite Modification Date:
2026-01-21 @ 2:18 PM
Study NCT ID:
NCT03100461
Status:
COMPLETED
Last Update Posted:
2024-10-15
First Post:
2017-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations
Sponsor:
University of Kansas Medical Center
Organization:
Study Overview
Official Title:
Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations
Status:
COMPLETED
Status Verified Date:
2020-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AIMSS
Brief Summary:
The goal of this study is to find the best ways to increase colorectal cancer (CRC) screening.
Detailed Description:
Colorectal Cancer is preventable and curable but is still the second most common cause of cancer death in the U.S. Minorities and those with low income have more CRC than middle and high income Whites.. They also get fewer CRC screening tests. Low knowledge of CRC screening may, in part, drive this lower test use. We need new ways to improve CRC screening in primary care clinics where many minority and uninsured patients receive health care.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 1R01CA188898-01A1 | NIH | None | https://reporter.nih.gov/quic… | View |